Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-27 @ 3:52 AM
Study NCT ID:
NCT01239368
Status:
TERMINATED
Last Update Posted:
2019-12-10
First Post:
2010-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-10
First Submit QC Date:
None
Study First Post Date:
2010-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-26
Results First Submit QC Date:
None
Results First Post Date:
2018-10-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-03
Last Update Post Date:
2019-12-10
Last Update Post Date Type:
ACTUAL